BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $820,000 | -99.3% | 15,217 | -99.1% | 0.00% | -99.0% |
| Q2 2022 | $110,372,000 | +30.2% | 1,718,390 | +57.1% | 0.20% | +54.7% |
| Q1 2022 | $84,800,000 | +943.4% | 1,093,622 | +1055.2% | 0.13% | +966.7% |
| Q4 2021 | $8,127,000 | +42.8% | 94,673 | +33.8% | 0.01% | +33.3% |
| Q3 2021 | $5,692,000 | -86.2% | 70,764 | -86.2% | 0.01% | -85.9% |
| Q2 2021 | $41,203,000 | -84.9% | 511,833 | -84.1% | 0.06% | -85.9% |
| Q1 2021 | $272,085,000 | +8.4% | 3,226,055 | +3.1% | 0.45% | +1.6% |
| Q4 2020 | $251,009,000 | -17.9% | 3,128,229 | -17.8% | 0.45% | -25.9% |
| Q3 2020 | $305,912,000 | -13.1% | 3,803,933 | -7.0% | 0.60% | -19.5% |
| Q2 2020 | $352,001,000 | +24.7% | 4,088,277 | +17.6% | 0.75% | +1.2% |
| Q1 2020 | $282,218,000 | +361.0% | 3,476,018 | +374.8% | 0.74% | +486.5% |
| Q4 2019 | $61,222,000 | +20.6% | 732,148 | +26.1% | 0.13% | +11.5% |
| Q3 2019 | $50,775,000 | -10.0% | 580,477 | -15.7% | 0.11% | -10.3% |
| Q2 2019 | $56,400,000 | -2.1% | 688,640 | -2.8% | 0.13% | -6.0% |
| Q1 2019 | $57,610,000 | -23.8% | 708,524 | -38.3% | 0.13% | -33.0% |
| Q4 2018 | $75,600,000 | -24.6% | 1,148,590 | -11.7% | 0.20% | -7.4% |
| Q3 2018 | $100,259,000 | -49.0% | 1,300,540 | -51.1% | 0.22% | -3.6% |
| Q2 2018 | $196,434,000 | +204.1% | 2,660,278 | +167.9% | 0.22% | +49.3% |
| Q1 2018 | $64,597,000 | +4.1% | 993,189 | +3.5% | 0.15% | +117.4% |
| Q4 2017 | $62,056,000 | +39.9% | 960,028 | +35.8% | 0.07% | -32.4% |
| Q3 2017 | $44,357,000 | -1.3% | 706,883 | -4.8% | 0.10% | -2.9% |
| Q2 2017 | $44,957,000 | -4.5% | 742,588 | -18.2% | 0.10% | -5.4% |
| Q1 2017 | $47,090,000 | +74.0% | 908,036 | +48.8% | 0.11% | +70.8% |
| Q4 2016 | $27,058,000 | +16.9% | 610,241 | +25.5% | 0.06% | +16.1% |
| Q3 2016 | $23,148,000 | -12.6% | 486,295 | -16.9% | 0.06% | -12.5% |
| Q2 2016 | $26,471,000 | -34.4% | 585,389 | -40.4% | 0.06% | -33.3% |
| Q1 2016 | $40,375,000 | +30.3% | 982,837 | +21.0% | 0.10% | +37.1% |
| Q4 2015 | $30,997,000 | +16.1% | 812,500 | -0.1% | 0.07% | +16.7% |
| Q3 2015 | $26,710,000 | -53.2% | 813,100 | -0.3% | 0.06% | -47.4% |
| Q2 2015 | $57,035,000 | -8.7% | 815,600 | -10.6% | 0.11% | -8.8% |
| Q1 2015 | $62,460,000 | -63.9% | 911,826 | -61.4% | 0.12% | -64.8% |
| Q4 2014 | $173,013,000 | -19.8% | 2,360,671 | -21.5% | 0.36% | -22.3% |
| Q3 2014 | $215,707,000 | -18.0% | 3,005,529 | -17.4% | 0.46% | -19.3% |
| Q2 2014 | $263,158,000 | -12.7% | 3,639,814 | -11.1% | 0.57% | -17.0% |
| Q1 2014 | $301,426,000 | +2.9% | 4,096,566 | -2.8% | 0.68% | -3.1% |
| Q4 2013 | $293,070,000 | +9.3% | 4,213,794 | +3.3% | 0.70% | -1.7% |
| Q3 2013 | $268,028,000 | +0.0% | 4,080,194 | +5.5% | 0.72% | -8.4% |
| Q2 2013 | $268,012,000 | – | 3,869,085 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |